The NENC Integrated Care System now has one governance procedure through the ICB Medicines Sub-Committee. This is supported by Northern Treatment Advisory Group (NTAG) and its subgroups. Until guidance can be reviewed by the ICB Medicines Sub-Committee and its sub-groups all guidance and agreements previously approved by the predecessor three Area Prescribing Committees (APCs) of County Durham & Tees Valley; North of Tyne, Gateshead & North Cumbria; and South Tyneside & Sunderland are still valid whilst within their review date. Clinicians referring to this guidance after any expiry date should exercise caution. ICB approved prescribing guidance and agreements will be hosted on the NTAG website moving forward and this is available publicly at https://ntag.nhs.uk/ .
Summaries of decisions made regarding new product requests are listed as appendices to minutes of committee meetings. The following is a list of the decisions made at the most recent committee meeting:
Decision Summaries
APC Decision Summary – January 2023
APC Decision Summary – October 2022
APC Decision Summary – July 2022
APC Decision Summary – April 2022
APC Decision Summary – January 2022
APC Decision Summary – October 2021
APC Decision Summary – July 2021
APC Decision Summary – April 2021
APC Decision Summary – January 2021
APC Decision Summary October 2020 v2
April and July 2020 APC Decision Summary
APC Decision Summary – January 2020
APC Decision Summary – October 2019
APC Decision Summary – July 2019
APC Decision Summary – April 2019
APC Decision Summary – January 2019
APC Decision Summary – October 2018
APC Decision Summary – July 2018
